Exosomes and immune surveillance of neoplastic lesions: a review.
The immune system has been reported to suppress the development and progression of neoplastic lesions; however, the exact mechanisms by which neoplastic lesions and the immune system interact are not well understood. Within the last decade, tiny membrane bound particles, approximately 30-100 nm in diameter, have been observed in the blood and other body fluids. These particles, currently called exosomes, are released from many types of tissues including tumors, and they contain and carry many proteins, and mRNAs and microRNA species. We review here how tumors suppress the immune system, especially by the formation of exosomes. Exosomes released from tumors are carried in part by the vascular system to distant cells, which phagocytose them. Depending on the proteins, mRNAs or microRNAs in the exosomes and the cell type, phagocytosis of exosomes may provide a modulating signal to the cell. In the case of exosomes from tumors, uptake of the exosomes by cells of the immune system has been reported to have three main effects: 1) suppression of the number and activity of natural killer cells, 2) suppression of the activity of T cells and 3) suppression of the number and maturation of mature dendritic cells.
James Brown Cancer Center, Department of Microbiology & Immunology, University of Louisville, Louisville, KY 40202, USA. H0zhan17@louisville.edu
H-G
HG
Zhang
X
X
Zhuang
D
D
Sun
Y
Y
Liu
X
X
Xiang
W E
WE
Grizzle
D000818:Animals; D001327:Autoimmune Diseases / Q000276:immunology; D003713:Dendritic Cells / Q000276:immunology; D055354:Exosomes / Q000276:immunology*; D006801:Humans; D007108:Immune Tolerance; D007157:Immunologic Surveillance; D007694:Killer Cells, Natural / Q000276:immunology; D018448:Models, Immunological; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy; D010587:Phagocytosis / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology